Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice

Allergologia et Immunopathologia

Volumn 39, Issue 4, 2011, Pages 206-211

  Hua, H ^a   Zhang, R ^a   Yu, S ^a,a   Wang, H ^a   Zhao, Y ^b   Li, W ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Matrix metalloproteinase 9; Tissue plasminogen activator

Indexed keywords

EOSIN; GELATINASE B; HEMATOXYLIN; OVALBUMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GIEMSA STAIN; HYPERPLASIA; MOUSE; NASAL MUCOSA MATRIX RECONSTRUCTION; NONHUMAN; NOSE RECONSTRUCTION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

AIRWAY REMODELING; ALLERGENS; ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; HYPERPLASIA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NASAL MUCOSA; OVALBUMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RHINITIS, ALLERGIC, PERENNIAL; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79960633388     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.09.010     Document Type: Article

References (16)

1. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008, 63(Suppl 86):8-160.
2. Salib R.J., Howarth P.H. Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease?. Clin Exp Allergy 2003, 33:1629-1633.
3. Bousquet J., Jacot W., Vignola A.M., Bachert C., Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways?. J Allergy Clin Immunol 2004, 113:43-49.
4. Sanai A., Nagata H., Konno A. Extensive interstitial collagen deposition on the basement membrane zone in allergic nasal mucosa. Acta Otolaryngol 1999, 119:473-478.
5. Kucharewicz I., Kowal K., Buczko W., Bodzenta-Łukaszyk A. The plasmin system in airway remodeling. Thromb Res 2003, 112:1-7.
6. Cook A.D., Vlahos R., Massa C.M., Braine E.L., Lenzo J.C., Turner A.L., et al. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation. Thromb Haemost 2006, 95:659-667.
7. Wang Y., Hu D.N., McCormick S.A., Savage H.E., O'Rourke J. Tissue plasminogen activator is released into cultured medium by cultured human uveal melanocytes. Pigment Cell Res 2002, 15:373-378.
8. Hsiao Y., Zou T., Ling C.C., Hu H., Tao X.M., Song H.Y. Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis. J Gastroenterol Hepatol 2008, 23(7 Pt 2):e258-e264.
9. Sejima T., Madoiwa S., Mimuro J., Sugo T., Ishida T., Ichimura K., et al. Expression profiles of fibrinolytic components in nasal mucosa. Histochem Cell Biol 2004, 122:61-73.
10. Sejima T., Madoiwa S., Mimuro J., Sugo T., Okada K., Ueshima S., et al. Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J Immunol 2005, 174:8135-8143.
11. Collen D. Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology Am Soc Hematol Educ Program 2001, 1-9.
12. van Toorenenbergen A.W., Gerth van Wijk R., Vermeulen A.M. Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid. Allergy 1999, 54:293-294.
13. Shaida A., Kenyon G., Devalia J., Davies R.J., MacDonald T.T., Pender S.L. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001, 108:791-796.
14. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 1990, 23:197-211.
15. Yamamoto K., Loskutoff D.J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996, 97:2440-2451.
16. Yang J., Shultz R.W., Mars W.M., Wegner R.E., Li Y., Dai C., et al. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002, 110:1525-1538.